|
|
Line 1: |
Line 1: |
− | {|class="wikitable sortable" style="width:90%;text-align:center"
| + | ==Annotated Information== |
− | |-
| + | ===Name=== |
− | !width="50"|LncBook ID
| + | Approved symbol: LINC02885 |
− | !width="50"|Symbol
| + | |
− | !width="50"|Synonyms
| + | Approved name: long intergenic non-protein coding RNA 2885 |
− | !width="50"|Functional Mechanism
| + | |
− | !width="50"|Biological Process
| + | HGNC ID: HGNC:41188 |
− | !width="50"|Disease
| + | |
− | !width="50"|Mesh Ontology
| + | Previous symbols: ISX-AS1 |
− | |-
| + | |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267755 HSALNT0267755]
| + | Previous names: ISX antisense RNA 1 |
− | |[[LINC02597]]
| + | |
− | |Transcriptional regulation
| + | RefSeq ID: NR_138042 |
− | |Pathogenic process
| |
− | |Postmenopausal osteoporosis (PMOP)
| |
− | |Musculoskeletal Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0178412 HSALNT0178412]
| |
− | |[[UVRAG-DT]]
| |
− | |Transcriptional regulation
| |
− | |Pathogenic process
| |
− | |Postmenopausal osteoporosis (PMOP)
| |
− | |Musculoskeletal Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185540 HSALNT0185540]
| |
− | |[[LINC02598]]
| |
− | |_
| |
− | |Pathogenic process
| |
− | |Lung squamous cell carcinoma (LUSC)
| |
− | |Neoplasms; Respiratory Tract Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0278274 HSALNT0278274]
| |
− | |[[SREBF2-AS1]]
| |
− | |_
| |
− | |Pathogenic process
| |
− | |Lung squamous cell carcinoma (LUSC)
| |
− | |Neoplasms; Respiratory Tract Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021177 HSALNT0021177]
| |
− | |[[LINC02602]]
| |
− | |_
| |
− | |Pathogenic process
| |
− | |Non-small cell lung cancer (NSCLC)
| |
− | |Neoplasms; Respiratory Tract Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021052 HSALNT0021052]
| |
− | |[[MIR205HG]]
| |
− | |CeRNA
| |
− | |Pathogenic process
| |
− | |Head & neck squamous cell carcinoma (HNSCC)
| |
− | |Neoplasms
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0107588 HSALNT0107588]
| |
− | |[[ZNF451-AS1]]
| |
− | |Transcriptional regulation
| |
− | |Pathogenic process
| |
− | |Pancreatic ductal adenocarcinoma (PDAC)
| |
− | |Neoplasms
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189537 HSALNT0189537]
| |
− | |[[SCAT2]]
| |
− | |_
| |
− | |Pathogenic process
| |
− | |Kidney clear cell carcinoma (KIRC)
| |
− | |Neoplasm
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0107867 HSALNT0107867]
| |
− | |[[SCAT8]]
| |
− | |_
| |
− | |Pathogenic process
| |
− | |Kidney clear cell carcinoma (KIRC)
| |
− | |Neoplasm
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0158500 HSALNT0158500]
| |
− | |[[LINC00707]]
| |
− | |Transcriptional regulation
| |
− | |Pathogenic process
| |
− | |Lung cancer (LC)
| |
− | |Neoplasms; Respiratory Tract Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185476 HSALNT0185476]
| |
− | |[[LINC02470]]
| |
− | |_
| |
− | |Pathogenic process
| |
− | |Non-small cell lung cancer (NSCLC) and overian cancer
| |
− | |Neoplasm
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0068302 HSALNT0068302]
| |
− | |[[LINC02600]]
| |
− | |_
| |
− | |Pathogenic process
| |
− | |Non-small cell lung cancer (NSCLC) and overian cancer
| |
− | |Neoplasm
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0123915 HSALNT0123915]
| |
− | |[[LINC02604]]
| |
− | |CeRNA
| |
− | |Pathogenic process
| |
− | |Glioblastoma
| |
− | |Neoplasms
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0160932 HSALNT0160932]
| |
− | |[[MACORIS]]
| |
− | |Transcriptional regulation
| |
− | |_
| |
− | |Cardiometabolic Diseases
| |
− | |Cardiovascular Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171022 HSALNT0171022]
| |
− | |[[KRTAP5-AS1]]
| |
− | |CeRNA
| |
− | |Pathogenic process
| |
− | |Gastric Cancer
| |
− | |Neoplasms; Digestive System Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215076 HSALNT0215076]
| |
− | |[[GSC-DT]]
| |
− | |_
| |
− | | Developmental process
| |
− | |_
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072605 HSALNT0072605]
| |
− | |[[CHAER1]]
| |
− | |Translational control
| |
− | |Pathogenic process
| |
− | |Cardiac hypertrophy
| |
− | |Cardiovascular Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027291 HSALNT0027291]
| |
− | |[[ODC1-DT]]
| |
− | |CeRNA
| |
− | |Pathogenic process
| |
− | |Head and neck carcinoma
| |
− | |Neoplasm
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0039409 HSALNT0039409]
| |
− | |[[MAP3K2-DT]]
| |
− | |_
| |
− | |Pathogenic process
| |
− | |Polycystic ovary syndrome (PCOS)
| |
− | |Female Urogenital Diseases and Pregnancy Complications
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0208284 HSALNT0208284]
| |
− | |[[ZFHX2-AS1]]
| |
− | |Transcriptional regulation
| |
− | |Developmental process
| |
− | |_
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0152349 HSALNT0152349]
| |
− | |[[LINC02603]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0081596 HSALNT0081596]
| |
− | |[[TENM3-AS1]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0165522 HSALNT0165522]
| |
− | |[[LINC00858]]
| |
− | |_
| |
− | |_
| |
− | |non-small cell lung cancer
| |
− | | Respiratory Tract Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281930 HSALNT0281930]
| |
− | |[[SCAT1]]
| |
− | |_
| |
− | |_
| |
− | |esophagal cancer
| |
− | |Digestive system Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0191750 HSALNT0191750]
| |
− | |[[LNCOG]]
| |
− | |_
| |
− | |_
| |
− | |osteogenic differenciation
| |
− | |Musculoskeletal Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246388 HSALNT0246388]
| |
− | |[[DCXR-DT]]
| |
− | |_
| |
− | |_
| |
− | |prostate cancer
| |
− | |Male Urogenital Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209659 HSALNT0209659]
| |
− | |[[NKX2-1-AS1]]
| |
− | |_
| |
− | |_
| |
− | |lung cancer
| |
− | | Respiratory Tract Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0038250 HSALNT0038250]
| |
− | |[[ACTR3-AS1]]
| |
− | |_
| |
− | |_
| |
− | |glioblastoma
| |
− | |Nervous system diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043145 HSALNT0043145]
| |
− | |[[ITGA6-AS1]]
| |
− | |_
| |
− | |_
| |
− | |glioblastoma
| |
− | |Nervous system diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281822 HSALNT0281822]
| |
− | |[[LINC02601]]
| |
− | |_
| |
− | |_
| |
− | |glioblastoma
| |
− | |Nervous system diseases
| |
− | |-
| |
− | |-
| |
− | |[[ZKSCAN7-AS1]]
| |
− | |_
| |
− | |_
| |
− | |glioblastoma
| |
− | |Nervous system diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120721 HSALNT0120721]
| |
− | |[[GARS-DT ]]
| |
− | |_
| |
− | |_
| |
− | |heroine addiction
| |
− | |Nervous system diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0093136 HSALNT0093136]
| |
− | |[[LINCADL]]
| |
− | |_
| |
− | |_
| |
− | |obesity
| |
− | |Digestive system Diseases
| |
− | |-
| |
− | |-
| |
− | |[[GPRACR]]
| |
− | |_
| |
− | |_
| |
− | |liver cancer
| |
− | |Digestive system Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0082561 HSALNT0082561]
| |
− | |[[LINC01060]]
| |
− | |_
| |
− | |_
| |
− | |pancreatic cancer
| |
− | |Digestive system Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0058704 HSALNT0058704]
| |
− | |[[TBILA]]
| |
− | |_
| |
− | |_
| |
− | |non-small cell lung cancer
| |
− | | Respiratory Tract Diseases
| |
− | |-
| |
− | |-
| |
− | |[[UGDH-AS1]]
| |
− | |_
| |
− | |_
| |
− | |invertebral disc degeneration
| |
− | |Musculoskeletal Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245777 HSALNT0245777]
| |
− | |[[TNRC6C-AS1]]
| |
− | |_
| |
− | |_
| |
− | |Thyroid cancer
| |
− | |Endocrine system Disease
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0225753 HSALNT0225753]
| |
− | |[[LINC02244]]
| |
− | |_
| |
− | |_
| |
− | |obesity
| |
− | |Digestive system Diseases
| |
− | |-
| |
− | |-
| |
− | |[[NKAIN3-IT1]]
| |
− | |_
| |
− | |_
| |
− | |glioblastoma
| |
− | |Nervous system diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013113 HSALNT0013113]
| |
− | |[[NGF-AS1]]
| |
− | |_
| |
− | |_
| |
− | |dysmenorhea
| |
− | |Female Urogenital Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0031057 HSALNT0031057]
| |
− | |[[LINC01121]]
| |
− | |_
| |
− | |_
| |
− | |pancreatic cancer
| |
− | |Digestive system Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234176 HSALNT0234176]
| |
− | |[[ARLNC1]]
| |
− | |_
| |
− | |_
| |
− | |prostate cancer
| |
− | |Male Urogenital Diseases
| |
− | |-
| |
− | |-
| |
− | |[[MPPED2-AS1]]
| |
− | |_
| |
− | |_
| |
− | |thyroid neoplasias
| |
− | |Endocrine system Disease
| |
− | |-
| |
− | |-
| |
− | |[[ZKSCAN2-DT]]
| |
− | |_
| |
− | |_
| |
− | |Hepatocellular carcinoma
| |
− | |Digestive system Diseases
| |
− | |-
| |
− | |-
| |
− | |[[LINC01703]]
| |
− | |_
| |
− | |_
| |
− | |Hepatocellular carcinoma
| |
− | |Digestive system Diseases
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144162 HSALNT0144162]
| |
− | |[[HPYR1]]
| |
− | |_
| |
− | |pathogenic process
| |
− | |H. pylori infection
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0172266 HSALNT0172266]
| |
− | |[[LINC00958]]
| |
− | |protein localization,transcriptional regulation
| |
− | |pathogenic process
| |
− | |bladder cancer, glioma
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167574 HSALNT0167574]
| |
− | |[[SH3PXD2A-AS1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |colorectal cancer
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[SSTR5-AS1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |neuroendocrine prostate cancer
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[TSPOAP1-AS1]]
| |
− | |_
| |
− | |pathogenic process
| |
− | |breast cancer
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[LINC00174]]
| |
− | |ceRNA
| |
− | |pathogenic process
| |
− | |colorectal carcinoma
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0169064 HSALNT0169064]
| |
− | |[[LINC01561]]
| |
− | |ceRNA
| |
− | |pathogenic process
| |
− | |breast cancer
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[LINC00514]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |neuroendocrine prostate cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282164 HSALNT0282164]
| |
− | |[[LINC02595]]
| |
− | |_
| |
− | |pathogenic process
| |
− | |colorectal cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197396 HSALNT0197396]
| |
− | |[[FZD10-AS1]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[LINC01567]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |colon cancer
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[ADPGK-AS1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |pancreatic cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0255381 HSALNT0255381]
| |
− | |[[RAB11B-AS1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |osteosarcoma
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237805 HSALNT0237805]
| |
− | |[[SNHG29]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |acute myeloid leukemia, rheumatoid arthritis
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[SNHG17]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |colorectal cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215138 HSALNT0215138]
| |
− | |[[DICER1-AS1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |osteosarcoma
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043929 HSALNT0043929]
| |
− | |[[TTN-AS1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |esophageal squamous cell carcinoma
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0152594 HSALNT0152594]
| |
− | |[[LINC00092]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |ovarian cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050704 HSALNT0050704]
| |
− | |[[THUMPD3-AS1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |Neuron death in stroke
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205980 HSALNT0205980]
| |
− | |[[LINC00554]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |liver cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0141703 HSALNT0141703]
| |
− | |[[ZFPM2-AS1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |multiple cancers, gastric carcinogenesis
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[HOXB-AS1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |autosomal dominant polycistic kidney disease
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167650 HSALNT0167650]
| |
− | |[[CFAP58-DT]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |innate immune response to viral infection
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[FAM230A]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[CPNE8-AS1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |cervical cancer
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[THORLNC]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |melanoma, skin squamous cell carcinoma,osteosarcoma, renal cell carcinoma
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[IATPR]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |breast cancer, gallbladder cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242280 HSALNT0242280]
| |
− | |[[PICART1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |breast cancer, colorectal cancer, lung cancer
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[LINC02599]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |breast cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183231 HSALNT0183231]
| |
− | |[[ETS1-AS1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |gastric cancer, neuroblastoma
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[MAPK6-DT]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |liver cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0036655 HSALNT0036655]
| |
− | |[[IL1R1-AS1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |Oral squamous cell carcinoma, breast cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001134 HSALNT0001134]
| |
− | |[[LINC01672]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | | Esophageal squamous cell carcinoma
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0135857 HSALNT0135857]
| |
− | |[[SIRLNT]]
| |
− | |ceRNA
| |
− | |pathogenic process
| |
− | | Breast cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0135484 HSALNT0135484]
| |
− | |[[LINC01605]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |Colon Cancer, Bladder cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0184552 HSALNT0184552]
| |
− | |[[GAU1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |Neuroblastoma and retinoblastoma
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287294 HSALNT0287294]
| |
− | |[[LINC00894]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |Lung adenocarcinoma
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0000250 HSALNT0000250]
| |
− | |[[LINC02593]]
| |
− | |_
| |
− | |pathogenic process
| |
− | |breast cancer, hepatocellular carcinoma
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0241060 HSALNT0241060]
| |
− | |[[LINC02594]]
| |
− | |_
| |
− | |_
| |
− | |gastric cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0022481 HSALNT0022481]
| |
− | |[[LINC01705]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |gastric cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0022477 HSALNT0022477]
| |
− | |[[LINC02474]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |gastric cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030809 HSALNT0030809]
| |
− | |[[LINC02590]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |gastric cancer
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0170966 HSALNT0170966]
| |
− | |[[MUC5B-AS1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | | lung adenocarcinoma
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275151 HSALNT0275151]
| |
− | |[[FAM230D]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275163 HSALNT0275163 ]
| |
− | |[[FAM230E]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275179 HSALNT0275179 ]
| |
− | |[[FAM230F]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[FAM230G]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[FAM230H]]
| |
− | |_
| |
− | |_
| |
− | |Papillary thyroid carcinoma
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[FAM230I]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275150 HSALNT0275150]
| |
− | |[[FAM230J]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0103387 HSALNT0103387]
| |
− | |[[HCG14]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |Celiac disease, Nutritional and Metabolic Diseases
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001419 HSALNT0001419]
| |
− | |[[LNCTAM34A]]
| |
− | |ceRNA
| |
− | |developmental process
| |
− | |Colon Cancer
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[LINC01510]]
| |
− | |transcriptional regulation, ceRNA
| |
− | |pathogenic process
| |
− | |Colorectal cancer, Non-small cell lung cancer
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[LNCOC1]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |Ovarian cancer
| |
− | |_
| |
− | |-
| |
− | |-
| |
− | |[[LGALSL-DT]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |Postmenopausal osteoporosis (PMOP)
| |
− | |_
| |
− | |-
| |
− | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002862 HSALNT0002862]
| |
− | |[[LINC02596]]
| |
− | |transcriptional regulation
| |
− | |pathogenic process
| |
− | |Postmenopausal osteoporosis (PMOP)
| |
− | |_
| |
− | |-
| |
− | |_
| |
− | |[[DEC1]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[RN7SK]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[RN7SL1]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[MYOPARR]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[PCED1B-AS1]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[UMLILO]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[LINC02631]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[BMNCR]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[ZEBTR]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[SNHG31]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[ILF3-DT]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[LINC00574]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[CEBPA-DT]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[BABAM2-AS1]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[SNHG30]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[RCC2-AS1]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[NIPBL-DT]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[PRDM16-DT]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[BCL6-AS1]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[C1orf220]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[MIR122HG]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[RB1-DT]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[PANTR1]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[C11orf72]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[CT66]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[CAPN10-DT]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[MIR1915HG]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[CT75]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[MIR9-3HG]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[RN7SL2]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[RN7SL3]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[CT70]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[CT69]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[FLVCR1-DT]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[C10orf91]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[CEP83-DT]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[CSTF3-DT]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[CTBP1-DT]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[FAM201B]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[MAFG-DT]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[RPP38-DT]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[CDRT3]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |[[DLEU2L]]
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |
− | |_
| |